Cite
HARVARD Citation
Lu, J. et al. (2019). Molecular insight into the T798M gatekeeper mutation-caused acquired resistance to tyrosine kinase inhibitors in ErbB2-positive breast cancer. Computational biology and chemistry. pp. 290-296. [Online].